CD8A and neoplasm: As the first line of defense, innate immune responses are critical in the onset and maintenance of T cell responses, including T-cell-centered tumor immunity.10 Briefly, antigen-presenting cells (APC) uptake and present tumor antigens via major histocompatibility complex I (MHC-I), and thereby induce tumor-specific CD8+ T cell expansion.